Nirvana Life Sciences (XCNQ:NIRV) Interest Expense : C$-0.01 Mil (TTM As of Jan. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Nirvana Life Sciences Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Nirvana Life Sciences's interest expense for the three months ended in Jan. 2024 was C$ 0.00 Mil. Its interest expense for the trailing twelve months (TTM) ended in Jan. 2024 was C$-0.01 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Nirvana Life Sciences's Operating Income for the three months ended in Jan. 2024 was C$ -0.17 Mil. Nirvana Life Sciences's Interest Expense for the three months ended in Jan. 2024 was C$ 0.00 Mil. Nirvana Life Sciences has no long-term debt ⁽¹⁾. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

(1) Note: An indication of "no long-term debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

Nirvana Life Sciences Interest Expense Historical Data

The historical data trend for Nirvana Life Sciences's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nirvana Life Sciences Interest Expense Chart

Nirvana Life Sciences Annual Data

Trend

Oct18

Oct19

Oct20

Oct21

Apr22

Apr23

Interest Expense

Get a 7-Day Free Trial

-0.01

Nirvana Life Sciences Quarterly Data
	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
Interest Expense	Get a 7-Day Free Trial															-	-0.01	-	-	-

Nirvana Life Sciences Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.01 Mil.

Nirvana Life Sciences (XCNQ:NIRV) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Nirvana Life Sciences's Interest Expense for the three months ended in Jan. 2024 was C$0.00 Mil. Its Operating Income for the three months ended in Jan. 2024 was C$-0.17 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Jan. 2024 was C$0.00 Mil.

Nirvana Life Sciences's Interest Coverage for the quarter that ended in Jan. 2024 is calculated as

Nirvana Life Sciences had no long-term debt ⁽¹⁾.

The higher the ratio, the stronger the company's financial strength is.

Nirvana Life Sciences (XCNQ:NIRV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nirvana Life Sciences Inc (XCNQ:NIRV) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

650 West Georgia Street, Suite 2110, Vancouver, BC, CAN, V6B 4N8

Website

https://www.nirvanalifescience.com

Nirvana Life Sciences Inc is focused on developing medical products and regimens that address addiction. The company is working on novel formulations of psilocybin and other naturally-sourced psychedelics to treat pain, opioid dependency, and other health problems.

Nirvana Life Sciences (XCNQ:NIRV) Headlines

No Headlines